Overview

The Bladder Instillation Comparison Study

Status:
Unknown status

Trial end date:
2019-04-01

Target enrollment:

Participant gender:

Summary

To compare the efficacy of Mitomycin C vs. Gemcitabine vs. no adjuvant treatment as a single intraoperative instillation in preventing recurrence of bladder cancer.

Phase:

Phase 3

Details

Lead Sponsor:

Spectrum Health Hospitals

Treatments:

Gemcitabine
Mitomycin
Mitomycins